News & Publications

On April 6, 2021, Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and treatment of metastatic cancer, announced the extension of its original $12 million seed round to a total of $44 million.

In 2020, we served as counsel in more than 200 venture financings raising in excess of $10 billion, including some of the largest and most prominent deals of the year. Since 2010, we have handled approximately 2,700 venture financings with total proceeds in excess of $48 billion.

On February 24, 2021, Xilio Therapeutics, a biotechnology company developing potent, tumor-selective immunotherapies for patients with cancer, announced the successful closing of a $95 million Series C financing round.

On February 9, 2021, WizeHire, a user-friendly, effective hiring solution for small businesses, announced the closing of $7.5 million in Series A funding.

Esme Learning Solutions, a leading digital learning platform, announced the close of a $7.5 million Series A financing round led by Adit Ventures, a venture capital firm with a technology thematic investment focus.  

On January 19, 2021, Verve Therapeutics, a biotech company pioneering gene editing medicines to treat cardiovascular disease, announced the successful completion of a $94 million Series B financing.

On January 7, 2021, Werewolf Therapeutics, an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments, announced the completion of its $72 million Series B financing.

On December 17, 2020, The Lifetime Value Co., a creator of leading online consumer and business information brands that helps people discover, understand and use data, announced a $150 million investment led by Morgan Stanley Expansion Capital with participation from investment funds managed by Morgan Stanley Credit Partners, Morgan Stanley Tactical Value, and ROCA Partners.

WilmerHale’s annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

The 2020 Venture Capital Report offers an in-depth US venture capital market review and outlook, including industry and regional breakdowns, as well as insights on a number of key topics.

On March 16, 2020, ZeroNorth announced that it raised a $10 million Series A+ funding round led by Crosslink Capital, along with existing investors ClearSky, Rally Ventures and Petrillo Capital.

In 2019, we served as counsel in more than 225 venture financings raising in excess of $5 billion, including some of the largest and most prominent deals of the year.

RunSafe Security, the pioneer of a patented process to immunize software without developer friction from cyber attacks, announced that it closed a $6.3 million Series A Round. 

1366 Technologies, developer of manufacturing solutions for silicon cell manufacturers, has raised $18M in Series E funding from both return investors and several new investors, including Breakthrough Energy Ventures.

Many innovative young businesses were showcased at Founders + Funders NYC, a gathering for entrepreneurs and investors hosted at WilmerHale's New York office on November 8.